<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: chemical substances by structure ZP ZQ20.4.4</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;chemical substances by structure.&nbsp;&nbsp;ZP - ZQ20.4.4</BIG></B></Center>
<CENTER><A HREF="aodob.htm#Z">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZP">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqz.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnzo.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP"><B>ZP</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>alkaloids</B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZP"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A diverse group of some 5,000 bitter compounds of plant origin containing nitrogen as well as carbon, oxygen, and hydrogen, that are usually physiologically or pharmacologically active (e.g.,
   producing mind-altering or toxic effects).  Most medicinal and toxic plants as well as hallucinogenic plants owe their biological activity to alkaloids.  Examples include caffeine, morphine, and
   nicotine.  (THC, the primary psychoactive ingredient in marijuana, is an exception.)  The term also is applied to synthetic (i.e., made by a chemical process) alkaloids, which have structures
   similar to plant alkaloids.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BF2.2 mescaline &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BJ4.4.2 arecoline &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YT10.2.2 ipecac &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT10-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT10-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQe opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT8.8.4e harmine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT8-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT8-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZMe organic nitrogen compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZM"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BJ4.4.4e betel nut &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BJ4.8 kava in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YT6.4.2 curare &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP2">ZP2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>bicuculline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW8.6 convulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.12e isoquinolines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP4">ZP4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cinchona alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP4-2">ZP4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>quinidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.2 antiarrhythmia agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.22e quinolines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-22"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-22"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP4-4">ZP4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>quinine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YQ4.10.4.2 antimalarials &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YQ4-10-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YQ4-10-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.22e quinolines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-22"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-22"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP4-6">ZP4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tubocurarine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP6">ZP6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>colchicine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YR2.2.6 gout suppressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP8">ZP8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>ergot alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Pharmacologically active ingredients of ergot used medicinally variously for the treatment of mood depression in elderly patients, the treatment of migraine headaches, and the inducement of uterine
   contractions in expectant mothers.  One of the many ergot alkaloids is lysergic amide, from which LSD-25 can be derived.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZT10 4 or more ring heterocyclic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP8-2">ZP8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ergoline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD>+BF4 lysergic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BF4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BF4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP8-4">ZP8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>bromocriptine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.2.4 dopaminergic anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.4 dopaminergic agonists for alcohol-concurrent mental disorders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP10.8.6 cocaine blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP10">ZP10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>ibogaine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.  ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>An hallucinogen and alkaloid from Tabernanthe iboga.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> 12-methoxyibogamine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.2.2 schedule I hallucinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW10e hallucinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.10e indoles &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP12">ZP12</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>physostigmine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YD8.4 cholinesterase inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV10e parasympathomimetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP14">ZP14</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pilocarpine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV10.4 ganglionic stimulants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP16">ZP16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>pyrrolizidine alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YX4e carcinogens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18">ZP18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>solanaceous alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BD2e nicotine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV8e parasympatholytics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-2">ZP18.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>capsaicin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-4">ZP18.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nicotinic acid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BJ4.4.2 arecoline &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.26.2.6.2e Bay K 8644 &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-26-2-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YB12e vitamin B complex &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT2 heterocyclic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-4-2">ZP18.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>niacin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YB12e vitamin B complex &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GH14.4.6.6e niacin deficiency &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH14-4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH14-4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-4-4">ZP18.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nimodipine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YT8.14e calcium channel blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT4.26.2.6e dihydropyridine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-26-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-26-2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-6">ZP18.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>belladonna alkaloid&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+ZP30e tropane &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP30"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP30"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-6-2">ZP18.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>atropine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+BT6.8.6 schedule IV opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP18-6-4">ZP18.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nicotinamide&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">BT</TD><TD>+YB12e vitamin B complex &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV8e parasympatholytics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP20">ZP20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>sparteine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.2 antiarrhythmia agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP22">ZP22</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>strychnine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YW8.6 convulsants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP24">ZP24</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>salsoline alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZT6.12e isoquinolines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP24-2">ZP24.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tetrahydroisoquinoline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> tetrahydroxyisoquinoline </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> THIQ </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> THQ </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> TIQ </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZQ12.2.2.2e tetrahydropapaveroline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ12-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZG2.4e acetaldehyde &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP24-2-2">ZP24.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>salsolinol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+ZG2.4e acetaldehyde &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP26">ZP26</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>rauwolfia alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP26"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YT8.8 antihypertensive agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YT8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YT8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.6 adrenergic neurohumor depleters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZT10.2e yohimban &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP26-2">ZP26.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>reserpine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP26-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>One of the alkaloids found in Rauwolfia serpentina (or snakeroot), a plant indigenous to India and neighboring countries, and used in a variety of antipsychotic tranquilizers.  Unlike some
   tranquilizers, it has no anticonvulsant or antihistaminic effects, although the phenothiazine derivatives such as chlorpromazine are preferred in medical and psychiatric practice.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZT10.2e yohimban &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP26-4">ZP26.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>yohimbine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP26-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV12.2e alpha-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT10.2e yohimban &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP28">ZP28</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>xanthine alkaloids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP28"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>BC2e caffeine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BC4 theophylline &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BC4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BC4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>WK4.6.4.12.2.2.2 Theobroma cacao &nbsp;&nbsp;&nbsp;<A HREF="aodhqw.htm#WK4-6-4-12-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnw.htm#WK4-6-4-12-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BC caffeine in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BC"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BC"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.18.2.2e xanthines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-18-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-18-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP30">ZP30</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>tropane&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP30"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD>+BK2e cocaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BK2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BK2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZP18.6e belladonna alkaloid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP18-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP18-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP30-2">ZP30.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>scopolamine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP30-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP30-2-2">ZP30.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>scopolamine derivative&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP30-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP32">ZP32</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>aporphines&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP32"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> aporphine alkaloids </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZP32-2">ZP32.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>apomorphine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP32-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Produced by reacting morphine with hydrochloric acid, resulting in structural changes.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.6e alcohol withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.10e conditioned alcohol aversion agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.12.4 dopaminergic agonists for alcohol-concurrent mental disorders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV4.2 dopaminergic agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+HK2.12.2e chemical aversion therapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ">ZQ</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>opioids&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZQ"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>This generic term applies to alkaloids from the opium poppy, their synthetic analogues, and related compounds synthesized in the body that interact with specific receptors in the brain, have the
   capacity to relieve pain, and produce a sense of well-being (euphoria).  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Opium alkaloids and their semisynthetic derivatives include morphine, diacetylmorphine (heroin), hydromorphine, codeine, and oxycodone.  Synthetic opioids
   include levorphanol, propoxyphene, methadone, meperidine (pethidine), and pentazocine.  Endogenously occurring compounds with opioid actions include the endorphins and enkephalins. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Opioid use disorders" (F11) are among the "mental and behavioral disorders due to psychoactive substance use" in ICD-10.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> opium alkaloids </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BL opioids in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.2.8 schedule I opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZPe alkaloids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YR2e analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YR2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YR2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4e CNS depressants &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ2">ZQ2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>opioids by chemical structure&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4">ZQ4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenanthrene derivative opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Changed descriptor 1995; through 1995 also use "morphinans."
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The prototype of this group is morphine.  The group also includes compounds that are morphinan derivatives, such as levorphanol.  The term morphinans is sometines used both in the narrow sense of
   morphinan derivatives and in the broad sense of morphine-like opioids.
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the poppy, the biosynthesis sequence is thebaine, codeine, then morphine.  Conversely, codeine can be produced from morphine.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> morphinan alkaloids </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> morphinans </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> morphine-like alkaloids </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> phenanthrene derivative alkaloids </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZT10 4 or more ring heterocyclic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2">ZQ4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>morphine and derivatives&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>In some classifications, this group includes codeine.  Here we use a narrower definition.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> morphine derivatives </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BL2e heroin &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.2.8.4 schedule I morphine derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-2-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-2-8-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2-2">ZQ4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>morphine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The principal active ingredient in opium.  (Raw opium is composed of approximately 10 percent morphine by weight.)  Isolated in 1803 and named after Morpheus, the Greek god of dreams, morphine first
   received widespread use in the United States during the Civil War.  Still one of the most useful of medical drugs, it is considered by some to be superior to all other pain relievers.  In addition
   to pain relief, it reduces drive states and encourages sleep.  Since the Harrison Narcotics Act and the spread of heroin use, the recreational use of morphine has declined, although the subjective
   effects of the two drugs in equivalent potencies are almost identical.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.6.6 schedule III opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.2e natural opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BL4 opioid product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BL4.2e opium &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BL6 Papaver somniferum &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2-4">ZQ4.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nalorphine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A semisynthetic derivative of morphine, manufactured as Nalline.  It counters the depression of the central nervous system created by opiate narcotics and is often valuable in the treatment of
   narcotic overdoses by abolishing respiratory depression.  Nalorphine precipitates pupil dilation in the presence of opiates, which is the basis for the Nalline test.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.6.6 schedule III opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2-6">ZQ4.2.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dihydromorphine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> hydromorphone hydrochloride </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2-8">ZQ4.2.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dihydromorphinone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Strong analgesic used for moderate to severe pain.  Also an antitussive.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Dilaudid </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> hydromorphone </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Hymorphan </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2-10">ZQ4.2.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>ethylmorphine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Used in ophthalmology
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Dionin </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.6.6 schedule III opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.10.4 schedule V opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-2-12">ZQ4.2.12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oxymorphone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">ST</TD><TD> Dihydrohydroxymorphinone </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-4">ZQ4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>codeine and derivatives&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-4-2">ZQ4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>codeine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The (natural) opiate methylmorphine, an alkaloid of opium that is usually extracted from morphine; it resembles the effect of, but with only 1/6th to 1/10th the analgesic action.  It is most often
   used as a pain reliever and an antitussive agent (e.g., in cough medicines).  The opioid propoxyphene hydrochloride has similar effects but without the side effects of constipation and nausea that
   codeine produces.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> methylmorphine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.6.6 schedule III opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.10.4 schedule V opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.2e natural opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BL4 opioid product &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BL4.2e opium &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BL6 Papaver somniferum &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-4-4">ZQ4.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>hydrocodone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A hydrogenated ketone derivative of codeine used as an analgesic and antitussive agent.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Dicodid </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> dihydrocodeinone </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BT6.6.6 schedule III opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.2e natural opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-4-6">ZQ4.4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oxycodone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A semisynthetic morphine derivative, manufactured as Percodan, Percocet-5, and Tylox.  Used to relieve moderate to moderately severe pain.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> dihydrohydroxycodeinone </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Percocet-5 </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Percodan </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Tylox </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-6">ZQ4.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thebaine and derivatives&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-6-2">ZQ4.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>thebaine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Thebaine is precursor for important drugs.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.4 schedule II opium and derivatives &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.2e natural opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-6-4">ZQ4.6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>naloxone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A semisynthetic derivative of thebaine.  An opiate narcotic antagonist, of short duration in action, useful intravenously but relatively ineffective in oral administration.  It reverses the features
   of opiate intoxication and is prescribed for the treatment of overdose from this group of drugs.A synthetic congener of oxymorphone hydrochloride.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> naloxone hydrochloride </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Narcan </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YL2.4 ethanol antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.2e anti-alcohol-intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.2.8 narcotic antagonist anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.2 anti opiate intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12.2.2 pure narcotic antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.4e semisynthetic opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT12 bridged-ring heterocyclic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-6-6">ZQ4.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>naltrexone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A pure opiate narcotic antagonist and analog of naloxone hydrochloride, developed by Endo Laboratories in 1963.  It has the qualities of being effective when taken orally, long acting, and relatively
   free of unpleasant side effects; it does not produce opiate withdrawal symptoms with sudden discontinuation.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.2.8 narcotic antagonist anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.8.6e alcohol blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.4 opiate detoxification agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.8.6 opiate blockers &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12.2.2 pure narcotic antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT12 bridged-ring heterocyclic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-8">ZQ4.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>morphinan and derivatives&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-8-2">ZQ4.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>levorphanol&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="33%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A synthetic morphinan derivative.  Strong analgesic used for moderate to severe and intractable pain.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Levo-Dromoran </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.2 schedule II opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-8-4">ZQ4.8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>levallorphan&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW12.2.2 pure narcotic antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ4-8-6">ZQ4.8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nalmefene&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP4.8.2.8 narcotic antagonist anti-alcohol-craving agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-8-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-8-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12.2.2 pure narcotic antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ6">ZQ6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oripavine derivative opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ6-2">ZQ6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>buprenorphine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A mixed antagonist/agonist with a long duration of action.  It requires less frequent administration than methadone; appears to block the toxic, euphorigenic, and dependence-producing effects of
   opiates; and acts as a competitive antagonist (like naltrexone) while producing cross-tolerance (like methadone).  Buprenorphine itself appears to produce little physical dependence; therefore,
   maintenance therapy could be easily terminated.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Buprenex </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP10.8 cocaine relapse prevention agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.8.4 opiate agonist maintenance agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW12.2.4 mixed narcotic agonists and antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW12-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW12-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ8">ZQ8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phenylpiperidine derivative opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZT4.10 fentanyl &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ8-2">ZQ8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>meperidine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A synthetic opioid that also is known as pethidine. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;One of the most widely used of the opioids, especially in childbirth and for relief of other severe pains.  A drug frequently preferred by opiate narcotic
   abusers in the medical professions, it has pharmacological effects similar to morphine.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Demerol </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> Mepergan </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> pethidine </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.2 schedule II opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT2 heterocyclic acid &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ10">ZQ10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>diphenylhaptane derivative opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ10-2">ZQ10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>methadone&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A synthetic opioid drug used in maintenance therapy for those dependent on opioids.  It has a long half-life and can be given orally once daily with supervision.  
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An opioid largely used in the maintenance treatment of heroin dependency because (1) it prevents heroin withdrawal symptoms; (2) it fulfills the addict's
   physical need for the drug; (3) at sufficiently high doses, it blocks the effects of heroin through cross-tolerance; thus, a shot of street heroin while undergoing methadone treatment will probably
   give no pleasurable effect; (4) it is a longer-acting drug than heroin, the average dose lasting 24 hours, thus making it more convenient to administer; (5) it is effective orally, thus breaking
   the reliance on the ritual of injection; and (6) it can be dispensed at a treatment center.  The ultimate aim is to wean addicts from heroin and the heroin lifestyle and allow them to adjust to a
   new lifestyle through which they can then withdraw from methadone and live drug free.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>HK2.10.2.2.2 methadone maintenance &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-10-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-10-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BT6.4.10.2 schedule II opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-4-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-4-10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.4 opiate detoxification agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.6 opiate withdrawal agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP12.8.4 opiate agonist maintenance agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZG4e ketones &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZG4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZG4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>GF2.28.4.2 nodding out &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GF2-28-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GF2-28-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ10-4">ZQ10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>LAAM&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>An opioid that has completed large-scale clinical trails as an alternative treatment drug to methadone.  Whereas methadone must be taken daily, LAAM dosage is three times a week, does not yield a
   quick high, and appears to provide a level, sustained effect.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> l-alpha-acetylmethadol </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> levo-alpha-acetyl methadol </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> levo-alpha-acetylmethadol </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YP12.8.4 opiate agonist maintenance agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP12-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP12-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ18e synthetic opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>HK2.10.2.2.2 methadone maintenance &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-10-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-10-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ12">ZQ12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>benzylisoquinoline derivative opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ12-2">ZQ12.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>papaverine&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A naturally occurring alkaloid of opium that acts to depress the heart and smooth muscles.  Unlike morphine and codeine, it has no analgesic, euphoric, or other central nervous system effects.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YV8e parasympatholytics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16.2e natural opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.12e isoquinolines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BL6 Papaver somniferum &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ12-2-2">ZQ12.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>papaveroline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD><TD WIDTH="5%">BT</TD><TD>+YV14.2.4e beta-adrenergic receptor agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ12-2-2-2">ZQ12.2.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>tetrahydropapaveroline&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12-2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="35%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> Norlaudansoline </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> tetrahydroxypapaveroline </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZP24.2e tetrahydroisoquinoline &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP24-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP24-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ14">ZQ14</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>opioids by origin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ16">ZQ16</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>opiates&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A group of alkaloids derived from the opium poppy, Papaver somniferum, that have the properties of inducing analgesia; euphoria; and in higher doses, stupor, coma, and respiratory depression.  The
   term "opiate" includes natural and semisynthetic opioids but excludes synthetic opioids and endogenous opioids.  For further information, see the scope note (SN) for *+ZQ opioids* <A
   HREF="aodhqz.htm#ZQ"><SMALL>qh</SMALL></A> <A HREF="aodhnzp.htm#ZQ"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+BT6.2.8.2 schedule I opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BT6-2-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BT6-2-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YW4.2e narcotic analgesics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YW4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YW4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YK8e opioid receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ16-2">ZQ16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>natural opiates&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Refers to opium and its two alkaloids codeine and morphine.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BL4.2e opium &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.2e morphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.2e codeine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.4e hydrocodone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.6.2e thebaine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ12.2e papaverine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ16-4">ZQ16.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>semisynthetic opiates&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Refers to the opiates derived from the two opium alkaloids morphine and codeine; examples are heroin (diacetylmorphine) and hydromorphone hydrochloride.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>BL2e heroin &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BL2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BL2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.4e nalorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.6e dihydromorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.8e dihydromorphinone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.10e ethylmorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.2.12 oxymorphone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.4e hydrocodone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.4.6e oxycodone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.6.4e naloxone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ18">ZQ18</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>synthetic opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Synthetic drugs manufactured to resemble the opium alkaloids morphine and codeine and their derivatives in action and effect. The principal synthetics are meperidine hydrochloride and its related
   drugs, levorphanol tartrate, methadone hydrochloride, pentazocine, and propoxyphene hydrochloride.  Also called "synthetic opiates."  Although semantically incorrect, opioid is sometimes used as a
   general term that includes all of the opium and opiumlike derivatives, natural and synthetic.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZJ2.6.6.2.2e propoxyphene &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.6.6e naltrexone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.8.2e levorphanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.8.4e levallorphan &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.8.6e nalmefene &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ6.2e buprenorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ8.2e meperidine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ10.2e methadone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ10.4e LAAM &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT4.10 fentanyl &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ZP32.2e apomorphine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZP32-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZP32-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20">ZQ20</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>endogenous opioids&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Naturally occurring brain neuropeptides that include at least two major families, the enkephalins and endorphins.  Both can interact with opiate-binding sites (receptors) and may thus modulate the
   perception of pain; endorphins, in addition, appear to modulate mood and responses to stressful stimuli.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> endogenous opioid peptides </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YK8e opioid receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20-2">ZQ20.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>endorphins&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Endogenous opioid biochemical compounds (peptides).  Substances produced by the body that resemble the opiates in their abilities to produce analgesia and a sense of well-being.  The term "endorphin"
   is used generally to refer to all of the endogenous opioid compounds and implies a pharmacological activity (analogous to the activity of the corticosteroid category of biochemicals) as opposed to
   a specific chemical formulation.  Endorphins have so far been found to be present only in vertebrate animals.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> opioid peptides </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YG30.2.2 lipotropin &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YG30-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YG30-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV4 neuroregulators &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ZO6.8.26.4e pro-opiomelanocortin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-8-26-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-8-26-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20-2-2">ZQ20.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>beta-endorphin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20-2-4">ZQ20.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>dynorphin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20-4">ZQ20.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>enkephalin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Specific chemical names for endorphin-type compounds; nethionine-enkephalin and leucine-enkephalin.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YK8e opioid receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20-4-2">ZQ20.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>leucine enkephalin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="ZQ20-4-4">ZQ20.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>methionine enkephalin&nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#Z">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#ZP">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqz.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnzo.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
